A systematic structure–activity relationship investigation of the lead compound 1 resulted the identification of several N-[(substituted alkyl) cycloalkanoyl]-4-[((2, 6-dichlorophenyl) carbonyl) amino]-l-phenylalanine derivatives as potent VCAM/VLA-4 antagonists. The ...